Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors von Brauer, Nickolas R., Kempen, Allison L., Hernandez, Delmis, Sintim, Herman O.

Volltext

Identification of a Selective FLT3 Inhibitor with Low Activity against VEGFR, FGFR, PDGFR, c‐KIT, and RET Anti‐Targets von Akwata, Desmond, Kempen, Allison L., Dayal, Neetu, Brauer, Nickolas R., Sintim, Herman O.

Volltext

Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo[4,3-f]quinoline scaffold with activities against acute myeloid leukemia von Kempen, Allison L., Brauer, Nickolas R., Sintim, Herman O.

Volltext

Discovery of imidazo[1,2-]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma von Akwata, Desmond, Kempen, Allison L, Lamptey, Jones, Dayal, Neetu, Brauer, Nickolas R, Sintim, Herman O

Volltext

Dual FLT3/haspin kinase inhibitor based on 3 H -pyrazolo[4,3- f ]quinoline scaffold with activities against acute myeloid leukemia von Kempen, Allison L, Brauer, Nickolas R, Sintim, Herman O

Volltext

Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo4,3-fquinoline scaffold with activities against acute myeloid leukemia von Kempen, Allison L, Brauer, Nickolas R, Sintim, Herman O

Volltext

Dual FLT3/haspin kinase inhibitor based on 3-pyrazolo[4,3-]quinoline scaffold with activities against acute myeloid leukemia von Kempen, Allison L, Brauer, Nickolas R, Sintim, Herman O

Volltext

Discovery of imidazo1,2-bpyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma von Akwata, Desmond, Kempen, Allison L, Lamptey, Jones, Dayal, Neetu, Brauer, Nickolas R, Sintim, Herman O

Volltext

Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema von Kempen, John H., MD, PhD, Sugar, Elizabeth A., PhD, Jaffe, Glenn J., MD, Acharya, Nisha R., MD, MS, Dunn, James P., MD, Elner, Susan G., MD, Lightman, Susan L., MD, PhD, Thorne, Jennifer E., MD, PhD, Vitale, Albert T., MD, Altaweel, Michael M., MD

Volltext